{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:13:33Z","timestamp":1786598013711,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There are few studies evaluating the outcomes associated with transurethral resection of the prostate (TURP) in extremely elderly men. Our objective was to assess the safety and efficacy of this procedure in this special population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>As part of an ethically approved study, retrospective review was carried out of all patients\u2009\u2265\u200985\u00a0years who underwent TURP between 2014 and 2023 at a tertiary centre. Data was collected on demographics including frailty status, operative data and complications. Treatment success was defined as catheter free status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over the study period, 194 patients (median age 87\u00a0years, IQR 86\u201389) underwent TURP, with a median follow-up of 6\u00a0years (IQR 3.5\u20138). The majority (68%) were ASA 3. 28% received home nursing assistance or were nursing home residents at the time of surgery. Median CCI score was 2 (IQR 1\u20133). 66% used anticoagulant medication. 97% received spinal anaesthesia and median operative time was 63\u00a0min (IQR 39\u201388). The intra-operative complication rate was 2.6%. The 30-day complication rate was 30% (Clavien-Dindo (CD) 1\u20132: 24%,\u2009\u2265\u2009CD 3: 5.7%). Among those with a catheter preoperatively (62%, n\u2009=\u2009120), 84% had achieved spontaneous voiding (n\u2009=\u2009101) at three month follow up. Overall, 93% were still alive at 1\u00a0year post surgery. The cumulative reoperation rate during study follow up was 7.2% at 1\u00a0year, 10.9% at 3\u00a0years, and 11.5% at 5\u00a0years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Treatment success for TURP in extremely elderly men (\u2265\u200985\u00a0years) is high, but the associated morbidity burden warrants the need for an individualised approach when considering men in this special population who are potential candidates for surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-025-05948-z","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T11:51:00Z","timestamp":1758714660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Transurethral resection of the prostate in the extreme elderly (\u2265\u200985 years): treatment success, morbidity and survival"],"prefix":"10.1007","volume":"43","author":[{"given":"Stephen","family":"Baug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Beisland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Arvei","family":"Moen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Odland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Blomquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Julieb\u00f8-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"2","key":"5948_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.eururo.2023.04.008","volume":"84","author":"S Gravas","year":"2023","unstructured":"Gravas S, Cornu JN, Gacci M (2023) EAU guidelines on the management of non-neurogenic male lower urinary tract symptoms. Eur Urol 84(2):207\u2013222","journal-title":"Eur Urol"},{"issue":"1","key":"5948_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12894-024-01582-w","volume":"24","author":"Z Ye","year":"2024","unstructured":"Ye Z, Wang J, Xiao Y, Luo J, Xu L, Chen Z (2024) Global burden of benign prostatic hyperplasia in males aged 60\u201390 years from 1990 to 2019: results from the global burden of disease study 2019. BMC Urol 24(1):193","journal-title":"BMC Urol"},{"issue":"3","key":"5948_CR3","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1016\/S2468-2667(25)00009-X","volume":"10","author":"N Steel","year":"2025","unstructured":"Steel N, Bauer-Staeb CMM, Ford JA, Abbafati C, Abdalla MA, Abdelkader A et al (2025) Changing life expectancy in European countries 1990\u20132021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Lancet Public Health 10(3):e172\u2013e188","journal-title":"Lancet Public Health"},{"issue":"10440","key":"5948_CR4","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"GBDF Collaborators","year":"2024","unstructured":"Collaborators GBDF (2024) Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet 403(10440):2204\u20132256","journal-title":"Lancet"},{"issue":"S2","key":"5948_CR5","first-page":"S-29","volume":"36","author":"MS Agrawal","year":"2022","unstructured":"Agrawal MS, Mishra DK (2022) Transurethral resection of prostate. J Endourol 36(S2):S-29-S\u221234","journal-title":"J Endourol"},{"issue":"1","key":"5948_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00345-025-05688-0","volume":"43","author":"P Juliebo-Jones","year":"2025","unstructured":"Juliebo-Jones P, Baug S, Tzelves L, Beisland C (2025) Ageing patients, missing evidence: the need for more research in the elderly. World J Urol 43(1):303","journal-title":"World J Urol"},{"key":"5948_CR7","doi-asserted-by":"publisher","first-page":"1185539","DOI":"10.3389\/fmed.2023.1185539","volume":"10","author":"X Ren","year":"2023","unstructured":"Ren X, Wang J, Wang Z, Yin Y, Li X, Tian Y et al (2023) Frailty as a risk marker of adverse lower urinary symptom outcomes in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate. Front Med 10:1185539","journal-title":"Front Med"},{"issue":"1","key":"5948_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00120-021-01642-1","volume":"61","author":"A Wiedemann","year":"2022","unstructured":"Wiedemann A, Gedding C, Heese M, Stein J, Manseck A, Kirschner-Hermanns R (2022) Quality of life for wearers of a suprapubic or transurethral bladder catheter as lifelong permanent care. Urologe A 61(1):18\u201330","journal-title":"Urologe A"},{"issue":"3","key":"5948_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00345-023-04292-4","volume":"41","author":"H Elmansy","year":"2023","unstructured":"Elmansy H, Hodhod A, Fathy M, Violette PD, Elshafei A, Zakaria AS et al (2023) Emergency holmium laser enucleation of the prostate (HoLEP): a novel approach in the management of refractory hematuria for patients with benign prostatic hyperplasia (BPH): a single-institution experience. World J Urol 41(3):805\u2013811","journal-title":"World J Urol"},{"key":"5948_CR10","unstructured":"T\u00fcrk C, Pet\u0159\u00edk A, Sarica K, Seitz C, Skolarikos A, Straub M, et al (2023) EAU Guidelines on Urolithiasis"},{"issue":"5","key":"5948_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/bju.15761","volume":"130","author":"G Maresca","year":"2022","unstructured":"Maresca G, Mc Clinton S, Swami S, El-Mokadem I, Donaldson JF (2022) Do men with bladder stones benefit from treatment of benign prostatic obstruction? BJU Int 130(5):619\u2013627","journal-title":"BJU Int"},{"key":"5948_CR12","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s00345-022-04179-w","volume":"40","author":"M Lotterst\u00e4tter","year":"2022","unstructured":"Lotterst\u00e4tter M, Seklehner S, Wimpissinger F (2022) Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study. World J Urol 40:3015\u20133020","journal-title":"World J Urol"},{"key":"5948_CR13","unstructured":"SVELIC O, Om L, RELIS O. Seponering av platehemmere og antikoagulantia f\u00f8r kirurgi."},{"key":"5948_CR14","unstructured":"Statistics OfN. Mortality Statistics (2023) [Available from: https:\/\/www.nomisweb.co.uk."},{"key":"5948_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00345-024-05437-9","volume":"43","author":"C Klein","year":"2025","unstructured":"Klein C, Anract J, Pinar U (2025) Comparative study of HoLEP in elderly patients with indwelling catheters: a retrospective dual-center study. World J Urol 43:75","journal-title":"World J Urol"},{"issue":"1","key":"5948_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-025-05699-x","volume":"43","author":"GM Pirola","year":"2025","unstructured":"Pirola GM, Castellani D, Naselli A, Fong KY, Biligere S, Dellabella M et al (2025) Endoscopic enucleation of the prostate in men aged 80 years and older. Outcomes from a global, large, and multicenter series using different energy sources and techniques. World J Urol 43(1):344","journal-title":"World J Urol"},{"key":"5948_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14103410","author":"C Giulioni","year":"2025","unstructured":"Giulioni C, Talle M, Papaveri A, Mengoni F, Orciani R, Pandolfo SD et al (2025) The implementation of trifecta score to assess the quality of holmium laser enucleation of the prostate in elderly patients: an analysis of perioperative and functional outcomes and the impact of age. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14103410","journal-title":"J Clin Med"},{"issue":"4","key":"5948_CR19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.eururo.2006.08.006","volume":"51","author":"R Ruszat","year":"2007","unstructured":"Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC et al (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51(4):1031\u20131038 (discussion 8-41)","journal-title":"Eur Urol"},{"issue":"3","key":"5948_CR20","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.5489\/cuaj.8482","volume":"18","author":"A MacDonald","year":"2023","unstructured":"MacDonald A, Fathy M, Nikoufar P, Hodhod A, Hadi RA, Vangala SK et al (2023) Safety and clinical outcomes of GreenLight laser prostatectomy in octogenarians. Can Urol Assoc J 18(3):E65","journal-title":"Can Urol Assoc J"},{"key":"5948_CR21","unstructured":"Statistics N. Life expectancy \u2013 remaining years for males and females at selected ages. Statbank Table 05375. 2025."},{"key":"5948_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15314","author":"P Aceto","year":"2021","unstructured":"Aceto P, Bassi P, Sollazzi L, Racioppi M, Fortunato G, Di Gianfrancesco L et al (2021) Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta-analysis. BJU Int. https:\/\/doi.org\/10.1111\/bju.15314","journal-title":"BJU Int"},{"issue":"6","key":"5948_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/iju.15432","volume":"31","author":"S Yajima","year":"2024","unstructured":"Yajima S, Masuda H (2024) The significance of G8 and other geriatric assessments in urologic cancer management: a comprehensive review. Int J Urol 31(6):607\u2013615","journal-title":"Int J Urol"},{"key":"5948_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.euros.2025.03.013","volume":"75","author":"P Juliebo-Jones","year":"2025","unstructured":"Juliebo-Jones P, Roth I, Moen CA, Gjengsto P, Beisland C (2025) National trends in medication prescriptions for male lower urinary tract symptoms and erectile dysfunction: findings from the Norwegian prescription database. Eur Urol Open Sci 75:89\u201393","journal-title":"Eur Urol Open Sci"},{"key":"5948_CR25","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S273686","author":"P Jones","year":"2021","unstructured":"Jones P, Siena G, Hameed BZ, Somani BK (2021) Emerging data on the safety and efficacy of transurethral water vapour therapy for benign prostatic hyperplasia. Res Rep Urol. https:\/\/doi.org\/10.2147\/RRU.S273686","journal-title":"Res Rep Urol"},{"issue":"5","key":"5948_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40258-015-0218-x","volume":"14","author":"A Ray","year":"2016","unstructured":"Ray A, Morgan H, Wilkes A, Carter K, Carolan-Rees G (2016) The urolift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a NICE medical technology guidance. Appl Health Econ Health Policy 14(5):515\u2013526","journal-title":"Appl Health Econ Health Policy"},{"key":"5948_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/17562872231198634","volume":"15","author":"L Tzelves","year":"2023","unstructured":"Tzelves L, Nagasubramanian S, Pinitas A, Julieb\u00f8-Jones P, Madaan S, Sienna G et al (2023) Transperineal laser ablation as a new minimally invasive surgical therapy for benign prostatic hyperplasia: a systematic review of existing literature. Ther Adv Urol 15:17562872231198634","journal-title":"Ther Adv Urol"},{"key":"5948_CR28","doi-asserted-by":"crossref","unstructured":"Godard L, Trivedi H, Narang G, Forbes CM (2025) Device profile of the iTind temporary implantable nitinol device for benign prostatic hyperplasia. Expert Review of Medical Devices (just-accepted)","DOI":"10.1080\/17434440.2025.2517173"},{"issue":"5","key":"5948_CR29","first-page":"646","volume":"76","author":"P Polverino","year":"2024","unstructured":"Polverino P, Lo Re M, Saladino M, Pecoraro A, Moscardi L, Rivetti A et al (2024) Could transperineal interstitial laser ablation of the prostate be the right option for highly-comorbid patients with lower urinary tract symptoms due to benign prostatic obstruction? A preliminary single-center experience focusing on functional and safety outcomes. Minerva Urol Nefrol 76(5):646\u2013649","journal-title":"Minerva Urol Nefrol"},{"issue":"4","key":"5948_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41391-023-00736-5","volume":"27","author":"P Destefanis","year":"2024","unstructured":"Destefanis P, Sibona M, Vitiello F, Vercelli E, Micai L, Montefusco G et al (2024) Trans - perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction. Prostate Cancer Prostatic Dis 27(4):693\u2013699","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"5948_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT et al (2024) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol 211(1):11\u201319","journal-title":"J Urol"},{"issue":"2","key":"5948_CR32","doi-asserted-by":"publisher","first-page":"e491","DOI":"10.1002\/bco2.491","volume":"6","author":"EL Alcina","year":"2025","unstructured":"Alcina EL, Arjona MF, Guzman EF, Zuazu JR, Jochamowitz IS (2025) Expert consensus on Rezum: indications, surgical technique and postoperative care. BJUI Compass 6(2):e491","journal-title":"BJUI Compass"},{"key":"5948_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1287212","volume":"14","author":"W He","year":"2023","unstructured":"He W, Ding T, Niu Z, Hao C, Li C, Xu Z et al (2023) Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review. Front Endocrinol (Lausanne) 14:1287212","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"5948_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2648.2007.04584.x","volume":"62","author":"H Godfrey","year":"2008","unstructured":"Godfrey H (2008) Living with a long-term urinary catheter: older people\u2019s experiences. J Adv Nurs 62(2):180\u2013190","journal-title":"J Adv Nurs"},{"key":"5948_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3711","volume":"363","author":"C Murphy","year":"2018","unstructured":"Murphy C, Cowan A, Moore K, Fader M (2018) Managing long term indwelling urinary catheters. BMJ 363:k3711","journal-title":"BMJ"},{"issue":"5","key":"5948_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489\u2013495","journal-title":"CMAJ"},{"issue":"8","key":"5948_CR37","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","volume":"23","author":"CA Bellera","year":"2012","unstructured":"Bellera CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M et al (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 23(8):2166\u20132172","journal-title":"Ann Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05948-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05948-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05948-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:49:33Z","timestamp":1773420573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05948-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5948"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05948-z","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PJJ has received funding from the Norwegian Institute of Urology to research surgical outcomes in the elderly population.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Regional Committee for Medical and Health Research Ethics (REK-no: 739374), and was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and its subsequent amendments. In compliance with the requirements set forth by the ethics committee, a negative (passive) informed consent process was employed: participants were informed about the study in writing and were included unless they explicitly declined participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}}],"article-number":"572"}}